COYA - Coya Therapeutics, Inc.

NasdaqCM - NasdaqCM 即時價格。貨幣為 USD。
-0.3700 (-8.10%)
收市:04:00PM EDT
4.4300 +0.23 (+5.48%)
收市後: 06:03PM EDT
買盤0.0000 x 900
賣出價0.0000 x 1300
今日波幅4.0900 - 4.7000
52 週波幅3.6850 - 8.0000
Beta 值 (5 年,每月)
市盈率 (最近 12 個月)
每股盈利 (最近 12 個月)-1.3700
遠期股息及收益率無 (無)
1 年預測目標價17.33
  • Benzinga

    Why Coya Therapeutics Shares Are Shooting Higher Today

    Coya Therapeutics Inc (NASDAQ: COYA) reported results from an open-label proof-of-concept clinical study for COYA 301 in patients with Alzheimer's disease. Treatment with COYA 301 resulted in a statistically significant improvement in cognitive function, as measured by the Mini-Mental State Examination test (MMSE), compared to the mean MMSE score at baseline (p=0.015). Consistent with the positive trend in MMSE score, mean scores in ADAS-Cog and CDR-SB scales did not significantly change at the

  • Benzinga

    Coya Therapeutics Reveals Proof-of-Concept Data From Small Study With ALS Patients

    Coya Therapeutics Inc (NASDAQ: COYA) reported 48-week clinical data for its proof-of-concept open-label study in 4 Amyotrophic Lateral Sclerosis (ALS) patients indicating that treatment with COYA 302 appeared to ameliorate disease progression. During the 48-week treatment period, COYA 302 appeared to be well tolerated. Preliminary efficacy of COYA 302 was measured by the ALSFRS-R scale, a validated rating tool for monitoring the progression of disability in ALS patients. The mean (±SD) ALSFRS-R